Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia (AML)

Explore clinical trials studying Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.

146 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia (AML) trial results

Recruiting

A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

NCT07623616

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Chiba Aoba Municipal Hospital Chiba, Japan
  • Gifu Municipal Hospital Gifu, Japan
  • Hyogo Medical University Hospital Hyōgo, Japan
  • Mito Medical Center Ibaraki, Japan
View all 20 locations
View Trial Details
Recruiting

A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS

NCT06372717

Conditions
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, +17 more
Locations
  • Monash Health Clayton, Victoria, Australia
  • St. Vincent's Hospital Melbourne Fitzroy, Victoria, Australia
  • The Alfred Hospital Melbourne, Victoria, Australia
  • Hollywood Private Hospital Nedlands, Western Australia, Australia
View Trial Details
Recruiting

VABu Conditioning in Elderly AML HSCT

NCT07583888

Conditions
Acute Myeloid Leukemia (AML), Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Hematologic Diseases, +6 more
Locations
  • The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
View Trial Details
Recruiting

An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.

NCT05907057

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • AKH - Medizinische Universität Wien Vienna, Austria
  • Klinikum Wels-Grieskirchen GmbH Wels, Austria
  • Institut Paoli Calmettes Marseille, Bouches-du-Rhône, France
  • CHU CAEN - Hôpital de la Côte de Nacre Caen, Calvados, France
View all 15 locations
View Trial Details
Recruiting

Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)

NCT03188874

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Klinikum Mittelbaden Baden-Baden, Baden-Wurttemberg, Germany
  • Universtitätsklinikum Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • Klinikum Mannheim GmbH Mannheim, Baden-Wurttemberg, Germany
  • Diakonie-Klinikum Schwäbisch Hall, Baden-Wurttemberg, Germany
View all 60 locations
View Trial Details
Recruiting

MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib

NCT07463651

Conditions
Acute Myeloid Leukemia (AML), Allogeneic Hematopoietic Cell Transplantation (HCT), FLT3-ITD Mutation, +10 more
Locations
  • the First Affiliated Hosptital of Soochow University Suzhou, Jiangsu, China
  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions